MDM2 and neoplasm: Our laboratory has also investigated novel and potent combinations of such MDM2 inhibitors with standard chemotherapy and demonstrated synergy with platinum drug treatments (but not gemcitabine) that resulted is tumor free survival in PDAC xenograft models [19].